Navigation Links
New chemo combination to fight breast cancer better

The New England Journal of Medicine reports the latest research done in Britain claim that new frontiers have been crossed in treating early breast //cancer successfully after having studied over 2,400 patients. The researchers of two independent studies apparently looked into the effectiveness of adding the drug epirubicin to regular chemotherapy employed to treat women in early stages of breast cancer. Both studies reported better results of treatment despite aggravation in side effects.

Most of the women who were part of the study were younger than 50 years. Half the number of women who underwent the program were administered the drug epirubicin while the rest were put on standard treatment.82% of those who received epirubicin as part of treatment lived for another 5 years and 76% of them lived on with no relapses. Whereas the group that received standard chemo therapy showed only 75% lived on to see another 5 years and only 69% showed no relapses.

Editorialists who were part of the study note that although chemotherapy reduces the risk of recurrence of breast cancer , its up to the doctors and patients during their course of clinical counseling to decide upon choice of treatment based on the pros and cons each therapy offers.
MST
'"/>




Page: 1

Related medicine news :

1. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
2. Using herbal remedies with chemotherapy may not be a good idea
3. Low doses of chemotherapy good for children
4. Treatment for chemobrain may be possible
5. Gossypol helps in chemotherapy of neck and head cancer.
6. Nanocells cancer combination therapy acts as chemotherapy as well as anti-angiogenic drug
7. Calls to combat deafness after chemotherapy
8. The bad combination
9. Warding off symptoms of premenstrual syndrome by combination therapy
10. Cholesterol can be lowered using combination of Soy Proteins and Sterols
11. Nanocells cancer combination therapy acts as chemotherapy as well as anti-angiogenic drug
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
Breaking Medicine Technology: